IntegraMed America's CEO Discusses Q1 2012 Results - Earnings Call Transcript

IntegraMed America, Inc.

Q1 2012 Earnings Call

May 3, 2012 10:00 AM ET

Executives

Jay Higham – Chairman, President and CEO

Tim Sheehan – SVP and CFO

Analysts

Frank DiLorenzo – Singular Research

Quentin Matthew

Presentation

Operator

Good morning everyone and thank you for participating in IntegraMed America Inc. First Quarter Conference Call. I am joined today by Jay Higham, President and CEO and Sheehan

Senior Vice President and CFO.

Before we begin I would like to caution that some of the comments made on this call may refer to certain measures such as adjusted EBITDA which are not calculated in accordance with generally accepted accounting principles or GAAP. Management believes these results are representative of the performance of the ongoing business of the company. For a reconciliation of adjusted EBITDA to GAAP results in accordance with Regulation G under the Securities Exchange Act please see IntegraMed Q1 press release which was filed today with the SEC on Form 8K and maybe found under the news tab of the company’s website.

The content of this conference call may contain time sensitive information that is accurate only as of today May 3, 2012, IntegraMed undertakes no obligation to revise or update any statements to reflect events or circumstances occurring after the date of this conference call. I will now turn the call over to Jay Higham, President & CEO, Jay?

Jay Higham

Thank you everybody and good morning. We appreciate you joining us on the call today. As our Q1 results demonstrate we have had a strong start to 2012 and are optimistic regarding our prospects for the balance of the year. I would like to review some of our business progress and then Tim Sheehan will provide some added color on our financial performance. Starting with our Attain Fertility Centers division during Q1 we entered into an agreement to manage the fertility clinic within the University of North Carolina Healthcare Systems.

UNCs fertility practice consistent of four respected reproductive endocrinologist, a lab director and staff. We like to support the clinics growth and success by providing them with a full array of IntegraMed support services and infrastructure that will enable the physicians to focus more patient care and to support the practices growth through sales and marketing, operations and revenue cycle management. To position the clinic to better serve the significant patient population in the region we will relocate the clinic to the research triangle park area a process that is targeted to the second half of 2012.

We also expanded our presence in the Florida market by completing in end market merger of the Palmetto Fertility Center in Miami Lakes, Florida with our IVF Florida operations. The Palmetto Center has expanded our leadership in South Florida with the addition of two well-regarded physicians, a lab director and office staff and a state of the art laboratory.

The transition IVF Florida operations to include nine physicians across six centers primarily in Miami, Dade and Broward Counties. We are very pleased with these transactions and we will remain focused on building our fertility network and growing the Attain IVF Program enrollment. We are also encouraged by the ongoing business development activity across the country. The innovative public, private partnership arrangement with the University of North Carolina is gaining visibility among other Academy Medical Centers is opening a new segment of the market to the benefits of working with IntegraMed.

We believe that big part of our success is being driven by our expanding online presence through our websites, attainfertility.com and attainivf.com and significant social media efforts. A considerable growth in traffic to our sites up three times quarter-over-quarter expanding consumer use of our innovative apps and dominant brand awareness translates into greater consumer education and the increase in patient enquiries to our partners and affiliates.

We have seen tremendous growth in our Attain Fertility Blog, YouTube channel and Facebook community. Our newest features attain fertility friends and ecards are quickly gaining popularity in our community as well. These interactive tools and expanded mobile marketing efforts extend the reach of our educational messages and help drive traffic to our fertility center network.

One innovative interactive tool we offer the attain fertility planner available at www.attainfertilityplanner.com. This tool has been approved by the U.S. FDA as a fertility diagnostic device. The free planner helps couples double the chance of conception by tracking and using simple body signs, test results, inoculation patterns to identify optimal timing for conception. It also helps track patient, helps patient track their data and understand when it's time to see a fertility specialist. Due to the strong patient demand for the planner, we will launch the iPhone and iPad app in Q2.

I will now turn to Attain IVF Program which provide unique financing options for patients seeking fertility treatment and are offered through our partner and affiliates patterns. Attain IVF programs are disconnected packages of services that improve patient success rates through a proven course of treatment focus. We offer patients low cost, financing through a third party partner to secure financing for this program.

Because of the programs value and attracting and retaining patients we are working to improve the quality and scope of our network by removing underperforming affiliates and seeking new practices. Attain IVF Program enrollments rose by more than 7% in Q1 2011 while applications declined due to the lingering impact of the recession. A seasonal decline in December enrollments and modest decrease in pregnancy rates during the period contributed to the division slight operating income decline in Q1.

Read the rest of this transcript for free on seekingalpha.com

More from Stocks

The Best Investment Advice? Stay Diversified

The Best Investment Advice? Stay Diversified

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Listen: Should You Buy Cisco Now?

Listen: Should You Buy Cisco Now?

Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business

Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business

Amazon's Assault on Grocery Stores Will Have a Profound Impact on Many

Amazon's Assault on Grocery Stores Will Have a Profound Impact on Many